Goro Healthcare launches Neopausil® in the United Arab Emirates
Goro Healthcare launches Neopausil® in the United Arab Emirates
As part of our commitment to improving patient access to novel therapies in Women’s Health, Goro Healthcare is proud to announce its launch of Neopausil®, an innovative therapy to treat menopausal and peri-menopausal symptoms, including hot flashes, vaginal dryness and pain, as well as helping to counter depression and aging.
Neopausil® is a combination of natural ingredients (Resveratrol, Vitamin D and Vitamin E), proven to reduce menopausal symptoms, and shown to be as effective as hormone replacement therapy (HRT). Its patented technology, FM-LipoMATRIX, improves the bioavailability and distribution of its active ingredients. Neopausil is
Announcing the launch of our Regional Distribution Framework
We are proud to announce Goro Healthcare’s partnerships with four of the largest distributors in the Gulf (GCC) region; Cigalah Group, City Pharmacy, Avanzcare and Al-Safa Group. This step marks a critical milestone to activating Goro Healthcare’s best-in-class distribution platform in the Middle East and ensures that we are able to deliver on our commitment to be an efficient, end-to-end, single entry partner for international healthcare companies seeking to expand in our region.
Since starting business activities in 1911, Saudi Arabian firm, Cigalah Group, has partnered with a vast number of
Goro Healthcare partners with Demophorius in the UAE and Qatar
Goro Healthcare is proud to announce our partnership with Demophorius to commercialize and distribute its high-quality medical devices in the UAE and Qatar. With this agreement, and leveraging our end-to-end commercialization suite, a new portfolio of high quality CE approved sutures, blood bags, gloves and consumables will be launched very soon for our patients in UAE and Qatar.
Demophorius Healthcare is a world leading and award-winning
Goro Healthcare signs an exclusive distribution agreement with Perfect Care Pharma
Goro Healthcare has signed an exclusive distribution agreement with European healthcare company, Perfect Care Pharma, expanding our offering in Women’s Health and General Medicine with the addition of two new products; Cerviron® and Hemoron®.
Cerviron® is used to treat multiple indications, including vaginal infections, cervical erosions, vulvar itching and for pre and postoperative treatment in gynecological surgery. The product is available as vaginal ovules.
Hemoron® suppositories are used to treat hemorrhoids and have been shown to reduce local pain and inflammation while helping regenerate damaged tissue and reducing bleeding.
Tanyx® obtains MOHAP registration approval
Goro Healthcare is proud to announce that Tanyx® – an innovative new concept in pain management – has been granted registration approval by the Ministry of Health And Prevention in the United Arab Emirates and launched in the country.
TANYX® is the world’s first US-FDA approved, self-applicable and portable TENS (Transcutaneous Electrical Nerve Stimulation) technology-based pain relief device with patents registered in over 40 countries to date.
Tanyx® is smaller than any other TENS device on the market and is
TANYX® speeds up Neymar’s recovery before match against Colombia:
Neymar uses TANYX® to accelerate his recovery, three days before playing against Colombia